A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia.

BACKGROUND:Pentavalent antimonials (Sb5) are the first-line drugs for treating cutaneous leishmaniasis in Colombia; however, given problems with toxicity, compliance, availability, and cost, it is imperative to look for better therapeutic options. Intravenous amphotericin B (AmB) has been used exten...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Liliana López, Iván Vélez, Claudia Asela, Claudia Cruz, Fabiana Alves, Sara Robledo, Byron Arana
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science (PLoS) 2018-07-01
Serija:PLoS Neglected Tropical Diseases
Online pristup:http://europepmc.org/articles/PMC6078324?pdf=render
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items